| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2023 | Sep 2021 | Sep 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 52.98B | 46.39B | 37.02B | 20.02B | 20.28B | 10.54B |
| Gross Profit | 29.24B | 24.81B | 22.26B | 12.17B | 15.74B | 7.83B |
| EBITDA | 14.52B | 15.01B | 11.43B | 6.34B | 9.85B | 4.78B |
| Net Income | 6.16B | 7.53B | 4.26B | 3.86B | 6.19B | 2.05B |
Balance Sheet | ||||||
| Total Assets | 126.35B | 104.79B | 93.83B | 52.94B | 42.73B | 17.09B |
| Cash, Cash Equivalents and Short-Term Investments | 25.52B | 30.18B | 38.40B | 25.10B | 31.79B | 8.14B |
| Total Debt | 30.39B | 34.47B | 24.02B | 3.41B | 1.68B | 2.81B |
| Total Liabilities | 71.19B | 55.12B | 43.90B | 13.61B | 7.22B | 7.69B |
| Stockholders Equity | 47.25B | 41.25B | 39.48B | 36.48B | 33.48B | 7.96B |
Cash Flow | ||||||
| Free Cash Flow | 12.44B | 7.65B | 11.10B | -3.06B | 3.29B | 5.01B |
| Operating Cash Flow | 12.62B | 7.84B | 12.20B | -811.00M | 3.53B | 5.04B |
| Investing Cash Flow | -3.09B | -14.08B | -13.74B | -7.68B | -832.00M | -269.82M |
| Financing Cash Flow | -14.83B | 1.32B | 17.83B | 1.41B | -193.00M | -549.03M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥86.37B | 19.07 | ― | 2.32% | 5.09% | 26.12% | |
74 Outperform | ¥29.21B | 35.99 | ― | ― | 29.61% | 93.16% | |
69 Neutral | ¥70.30B | 3.24 | ― | 1.47% | ― | ― | |
68 Neutral | ¥37.57B | -348.86 | ― | 3.99% | 1.27% | 26.79% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
46 Neutral | ¥99.94B | 15.20 | 2.57% | 1.97% | 19.61% | ― |